NHS England invites 75–80-year-olds for their first respiratory syncytial virus (RSV) vaccines – why should not those in their 80s be included too?
Saved in:
| Main Author: | Hamid A. Merchant |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2477761 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
80 at 80
by: Richard Mills, et al.
Published: (2022-09-01) -
V. Sergiev – 80
by: Article Editorial
Published: (2023-09-01) -
The 80/20 Rule
by: Murat Yılmaz
Published: (2005-09-01) -
Health Problems of 80 Plus Patients Reporting to the Hospital Emergency Department, Including Neurological Problems
by: Mariola Głowacka, et al.
Published: (2020-06-01) -
Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
by: Envera Lekic, et al.
Published: (2024-05-01)